APA (7th ed.) Citation

BoRa Lee, Dae Gyu Kim, Aram Lee, Young Mi Kim, Lianji Cui, Sunghoon Kim, & Inhee Choi. (2023). Synthesis and discovery of the first potent proteolysis targeting chimaera (PROTAC) degrader of AIMP2-DX2 as a lung cancer drug. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

BoRa Lee, Dae Gyu Kim, Aram Lee, Young Mi Kim, Lianji Cui, Sunghoon Kim, and Inhee Choi. Synthesis and Discovery of the First Potent Proteolysis Targeting Chimaera (PROTAC) Degrader of AIMP2-DX2 as a Lung Cancer Drug. Taylor & Francis Group, 2023.

MLA (9th ed.) Citation

BoRa Lee, et al. Synthesis and Discovery of the First Potent Proteolysis Targeting Chimaera (PROTAC) Degrader of AIMP2-DX2 as a Lung Cancer Drug. Taylor & Francis Group, 2023.